Boris Oklander Email

Co-Founder, GM & CTO . C2i Genomics

New York, NY

Location

Current Roles

Employees:
63
Revenue:
$14.8M
About
C2i Genomics is the first company to offer post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA. Our liquid biopsy Whole Genome assay and cancer burden score will equip oncologists with vital timely information months to years before current monitoring methods are able to.
C2i Genomics Address
180 Varick St,
New York, NY
United States
C2i Genomics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.